Antiplatelet therapy - Part I

Medicine and Dentistry

• Antiplatelet 100%
• Antiplatelet Drug 66%
• Apoplexy 33%
• Atrial Fibrillation 33%
• Clinical Trial 33%
• Heart Disease 33%
• Coronary Artery 33%
• Secondary Prevention 33%
• Heart Valve Prosthesis 33%
• Vascular Disease 33%
• Blood Clot Lysis 33%
• Acetylsalicylic Acid 33%
• Myocardial Infarction 33%
• Peripheral Vascular Disease 33%
• Primary Prevention 33%
• Stable Angina 33%
• Transluminal Coronary Angioplasty 33%
• Saphenous Vein Graft 33%

Keyphrases

• Antiplatelet Therapy 100%
• Primary Prevention 33%
• Clinical Trials 33%
• Atrial Fibrillation 33%
• Coronary Artery 33%
• Clinical Practice 33%
• Secondary Prevention 33%
• Antiplatelet Agents 33%
• Cardiac Disease 33%
• Vascular Disease 33%
• Myocardial Infarction 33%
• Aspirin 33%
• Peripheral Vascular Disease 33%
• Cardiac Valves 33%
• Coronary Angioplasty 33%
• Coronary Thrombolysis 33%
• Chronic Stable Angina 33%
• Antiplatelet Drugs 33%
• Saphenous Vein Bypass Graft 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiplatelet 100%
• Antithrombocytic Agent 66%
• Clinical Trial 33%
• Atrial Fibrillation 33%
• Heart Disease 33%
• Vascular Disease 33%
• Acetylsalicylic Acid 33%
• Heart Infarction 33%
• Peripheral Vascular Disease 33%
• Stable Angina Pectoris 33%